YPOG advised Aignostics on the deal. Aignostics, a spin-off from Charité – Universitätsmedizin Berlin, developing novel digital pathology solutions with “Explainable AI” for pharmaceutical research and...
This content is for Standard 1 Year members only. LoginJoin Now